Zolbetuximab (IMAB362)

zolbetuximab · Astellas Pharma China, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Zolbetuximab (IMAB362), covering 2024-11-20 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer [Phase 2]